QT
Healthcare & Life Sciences
Quell Therapeutics
United Kingdom
Quell Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Quell Therapeutics
Quell Therapeutics is a company headquartered in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Develops engineered regulatory T cell (Treg) therapies aimed at downregulating pathological immune responses to treat immune-mediated diseases.
Explore Quell Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.